Skip to main content
Caplight Logo









Psylaris

Psylaris

Private
MaastrichtHealthcare & Life Scienceshttps://psylaris.com/

Last Round

VC Round

Oct 22, 2025

Est. Valuation

$2M

Total Funding Raised

$245,000

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Psylaris is a health-tech company that develops virtual reality software for the mental healthcare sector, offering tools for therapists to deliver treatments such as EMDR, exposure therapy, and relaxation techniques.

Sector

Healthcare & Life Sciences

Verticals

Mental Health, AR/VR Experiences, Vertical SaaS

Business Model

B2B

Customer Profile

Subscription SaaS, Hardware + Subscription

AI Layer

Application

Keywords

virtual reality therapyVR therapyEMDReye movement desensitization and reprocessingmental health softwaredigital therapeuticsclinical management portalVR healthcareSaaS mental healthexposure therapyhealth techtherapy automationclinical workflowtelehealth tools

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Psylaris Comparables

Compare Psylaris with similar companies based on industry and business-model similarity.

Psylaris comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
CleVR B.V.
87%
PsyTechVR
81%
Vrendle
78%

Psylaris Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundOct 22, 2025
VC RoundApr 13, 2023
VC RoundJul 8, 2021
SeedFeb 1, 2019
SeedMar 21, 2018

Key People

Founding team and executive leadership

Mike Verhiel

CEO

Executive Team

Psylaris Investors

Notable investors and investment history

Psylaris investors
InvestorRounds
Brightlands Venture PartnersVC Round
LIOFVC Round, Seed
Y CombinatorSeed
Shaping Impact GroupVC Round
CbusineZVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 16, 2026

    Added ARQ International, a healthcare/non-profit SMB, as a customer.

  • May 16, 2026

    Added Frontier Capital Trust as a customer.

Psylaris Filings

Explore SEC and related filing metadata, where available.

Psylaris filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Psylaris's valuation, stock price, and market status.

Is Psylaris a public or private company?

Psylaris is a private company.

What is the current stock price of Psylaris?

Psylaris is a private company with no public stock price. No recent secondary market data is available.

How much is Psylaris worth (valuation)?

Psylaris's valuation is estimated at $2.0M based on funding round data.

Can I buy Psylaris stock?

Psylaris shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Psylaris's last funding round?

Psylaris's most recent funding round was VC Round on March 21, 2018.

Who are the main investors in Psylaris?

Key investors in Psylaris include LIOF, Y Combinator.

Will Psylaris IPO soon?

No public IPO plans have been announced for Psylaris.

How can I track Psylaris secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Psylaris's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersMaastricht
Employee Range25
Year Founded2017
Last FundingOct 22, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?